Cargando…

The Breast Cancer Stem Cells Traits and Drug Resistance

Drug resistance is a major challenge in breast cancer (BC) treatment at present. Accumulating studies indicate that breast cancer stem cells (BCSCs) are responsible for the BC drugs resistance, causing relapse and metastasis in BC patients. Thus, BCSCs elimination could reverse drug resistance and i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Qinghui, Zhang, Mengdi, Zhou, Fangfang, Zhang, Long, Meng, Xuli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876385/ https://www.ncbi.nlm.nih.gov/pubmed/33584277 http://dx.doi.org/10.3389/fphar.2020.599965

Ejemplares similares

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023)

A Review of Gut Microbiota‐Derived Metabolites in Tumor Progression and Cancer Therapy
por: Yang, Qiqing, et al.
Publicado: (2023)

Editorial: Epigenetic drugs and therapeutic resistance for epithelial malignancies
por: Tao, Fangfang, et al.
Publicado: (2023)

Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms to Treatment Response
por: Qiu, Jie, et al.
Publicado: (2021)

Polyherbal formulation conjugated to gold nanoparticles induced ferroptosis in drug-resistant breast cancer stem cells through ferritin degradation
por: Chittineedi, Prasanthi, et al.
Publicado: (2023)

PHD Finger Protein 19 Enhances the Resistance of Ovarian Cancer Cells to Compound Fuling Granule by Protecting Cell Growth, Invasion, Migration, and Stemness
por: Ruan, Shanming, et al.
Publicado: (2020)

Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
por: Zhang, Shuhui, et al.
Publicado: (2020)

Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
por: Mazurakova, Alena, et al.
Publicado: (2023)

Research progress on pleiotropic neuroprotective drugs for traumatic brain injury
por: Zhao, Qinghui, et al.
Publicado: (2023)

A Review of Extracellular Vesicles in COVID‐19 Diagnosis, Treatment, and Prevention
por: Su, Peng, et al.
Publicado: (2023)

Network Pharmacology-Based Validation of Caveolin-1 as a Key Mediator of Ai Du Qing Inhibition of Drug Resistance in Breast Cancer
por: Wang, Neng, et al.
Publicado: (2018)

Exosome-Based Cancer Therapy: Implication for Targeting Cancer Stem Cells
por: Wang, Jinheng, et al.
Publicado: (2017)

Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer
por: Xu, Yuhao, et al.
Publicado: (2022)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Drug-Loaded Polymeric Nanoparticles for Cancer Stem Cell Targeting
por: Li, Binbin, et al.
Publicado: (2017)

Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies
por: Wu, Xiaofan, et al.
Publicado: (2022)

Effect of Wenxia Changfu Formula Combined With Cisplatin Reversing Non-Small Cell Lung Cancer Cell Adhesion-Mediated Drug Resistance
por: Wang, Meng-Ran, et al.
Publicado: (2020)

Nanomedicine-Mediated Therapies to Target Breast Cancer Stem Cells
por: He, Lili, et al.
Publicado: (2016)

IQGAP3 Overexpression Correlates With Poor Prognosis and Radiation Therapy Resistance in Breast Cancer
por: Hua, Xin, et al.
Publicado: (2021)

Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond
por: Feng, Jianwei, et al.
Publicado: (2022)

Prostate Cancer Stem Cells and Nanotechnology: A Focus on Wnt Signaling
por: Qin, Wei, et al.
Publicado: (2017)

Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting
por: Lu, Bing, et al.
Publicado: (2016)

miRNAs in anti-cancer drug resistance of non-small cell lung cancer: Recent advances and future potential
por: Yan, Hang, et al.
Publicado: (2022)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
por: Tzeng, Yen-Dun Tony, et al.
Publicado: (2018)

Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
por: Bai, Jing-Wen, et al.
Publicado: (2020)

A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells
por: Han, Yu, et al.
Publicado: (2019)

Clinically-Relevant ABC Transporter for Anti-Cancer Drug Resistance
por: Xiao, Huan, et al.
Publicado: (2021)

Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
por: Dong, Chao, et al.
Publicado: (2021)

The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms
por: Rezaee, Malihe, et al.
Publicado: (2023)

Constructing a cancer stem cell related prognostic model for predicting immune landscape and drug sensitivity in colorectal cancer
por: Chen, Jianfang, et al.
Publicado: (2023)

Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
por: Xu, Yishi, et al.
Publicado: (2023)

Colocynth Extracts Prevent Epithelial to Mesenchymal Transition and Stemness of Breast Cancer Cells
por: Chowdhury, Kaushik, et al.
Publicado: (2017)

Mechanisms and insights into drug resistance in cancer
por: Zahreddine, Hiba, et al.
Publicado: (2013)

Combating and overcoming drug resistance in cancer
por: Price, Douglas K.
Publicado: (2014)

Autophagy Blockade by Ai Du Qing Formula Promotes Chemosensitivity of Breast Cancer Stem Cells Via GRP78/β-Catenin/ABCG2 Axis
por: Liao, Mianmian, et al.
Publicado: (2021)

Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
por: Li, Zhen, et al.
Publicado: (2020)

Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy
por: Wu, Yafei, et al.
Publicado: (2020)

Transcriptomics and Metabolomics Identify Drug Resistance of Dormant Cell in Colorectal Cancer
por: Xie, Lang, et al.
Publicado: (2022)

PARP inhibitor resistance in breast and gynecological cancer: Resistance mechanisms and combination therapy strategies
por: Wang, Nannan, et al.
Publicado: (2022)

Understanding the Emerging Link Between Circadian Rhythm, Nrf2 Pathway, and Breast Cancer to Overcome Drug Resistance
por: Bevinakoppamath, Supriya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m9qc9q282fg6spjo2iv79vi9hn